共 6 条
[1]
[2]
[3]
[4]
[5]
Downregulating hypoxia‐inducible factor‐2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma.[J].ChangjunHe;Xue‐PuSun;HaiquanQiao;XianJiang;DongdongWang;XiangguoJin;XuesongDong;JizhouWang;HongchiJiang;XueyingSun.Cancer Science.2012, 3

